{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:43:27Z","timestamp":1766807007682},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018,8,24]]},"DOI":"10.1253\/circj.cj-17-1032","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T22:42:30Z","timestamp":1529534550000},"page":"2269-2276","source":"Crossref","is-referenced-by-count":23,"title":["Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1\u3000\u2015 Modified Schwartz Score \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Junichi","family":"Ozawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"},{"name":"Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"},{"name":"Center for Epidemiologic Research in Asia, Shiga University of Medical Science"},{"name":"Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. Cardiac channel molecular autopsy: Insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. <i>Mayo Clin Proc<\/i> 2012; 87: 524\u2013539.","DOI":"10.1016\/j.mayocp.2012.02.017"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Leenhardt A, Denjoy I, Guicheney P. Catecholaminergic polymorphic ventricular tachycardia. <i>Circ Arrhythm Electrophysiol<\/i> 2012; 5: 1044\u20131052.","DOI":"10.1161\/CIRCEP.111.962027"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tester DJ, Ackerman MJ. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies\/channelopathies in clinical practice. <i>Circulation<\/i> 2011; 123: 1021\u20131037.","DOI":"10.1161\/CIRCULATIONAHA.109.914838"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nyegaard M, Overgaard MT, S\u00f8ndergaard MT, Vranas M, Behr ER, Hildebrandt LL, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. <i>Am J Hum Genet<\/i> 2012; 91: 703\u2013712.","DOI":"10.1016\/j.ajhg.2012.08.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Roux-Buisson N, Cacheux M, Fourest Lieuvin A, Fauconnier J, Brocard J, Denjoy I, et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. <i>Hum Mol Genet<\/i> 2012; 21: 2759\u20132767.","DOI":"10.1093\/hmg\/dds104"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Goldenberg I, Moss AJ. Long QT syndrome. <i>J Am Coll Cardiol<\/i> 2008; 51: 2291\u20132300.","DOI":"10.1016\/j.jacc.2008.02.068"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent M, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. <i>Circulation<\/i> 2001; 103: 89\u201395.","DOI":"10.1161\/01.CIR.103.1.89"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. <i>Circulation<\/i> 2002; 106: 69\u201374.","DOI":"10.1161\/01.CIR.0000020013.73106.D8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. <i>Heart Rhythm<\/i> 2005; 2: 1099\u20131105.","DOI":"10.1016\/j.hrthm.2005.07.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, et al. Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. <i>Heart<\/i> 2003; 89: 66\u201370.","DOI":"10.1136\/heart.89.1.66"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hayashi M, Denjoy I, Extramiana F, Maltret A, Roux Buisson N, Lupoglazoff JM, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. <i>Circulation<\/i> 2009; 119: 2426\u20132434.","DOI":"10.1161\/CIRCULATIONAHA.108.829267"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. <i>JAMA<\/i> 2004; 292: 1341\u20131344.","DOI":"10.1001\/jama.292.11.1341"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: The role of left cardiac sympathetic denervation. <i>Circulation<\/i> 2015; 131: 2185\u20132193.","DOI":"10.1161\/CIRCULATIONAHA.115.015731"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. <i>Circulation<\/i> 2004; 109: 1826\u20131833.","DOI":"10.1161\/01.CIR.0000125523.14403.1E"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. <i>Nat Med<\/i> 2009; 15: 380\u2013383.","DOI":"10.1038\/nm.1942"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A, et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. <i>J Am Coll Cardiol<\/i> 2011; 57: 2244\u20132254.","DOI":"10.1016\/j.jacc.2011.01.026"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Watanabe H, van der Werf C, Roses-Noguer F, Adler A, Sumitomo N, Veltmann C, et al. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. <i>Heart Rhythm<\/i> 2013; 10: 542\u2013547.","DOI":"10.1016\/j.hrthm.2012.12.035"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. <i>J Am Coll Cardiol<\/i> 2003; 41: 633\u2013642.","DOI":"10.1016\/S0735-1097(02)02850-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. <i>Genet Med<\/i> 2017; 17: 405\u2013424.","DOI":"10.1038\/gim.2015.30"},{"key":"20","unstructured":"20. Bazett H. An analysis of the time relations of electrocardiograms. <i>Heart<\/i> 1920; 7: 353\u2013370."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rijnbeek PR, Witsenburg M, Schrama E, Hess J, Kors A. New normal limits for the paediatric electrocardiogram. <i>Eur Heart J<\/i> 2001; 22: 702\u2013711.","DOI":"10.1053\/euhj.2000.2399"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. <i>Am Heart J<\/i> 1973; 85: 546\u2013562.","DOI":"10.1016\/0002-8703(73)90502-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. <i>Circulation<\/i> 2011; 124: 2181\u20132184.","DOI":"10.1161\/CIRCULATIONAHA.111.062182"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rosol Z, Miranda DF, Sandoval Y, Bart BA, Smith SW, Goldsmith SR. The effect of targeted temperature management on QT and corrected QT interval in patients with cardiac arrest. <i>J Crit Care<\/i> 2017; 39: 182\u2013184.","DOI":"10.1016\/j.jcrc.2017.02.030"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kosuge M, Ebina T, Hibi K, Iwahashi N, Tsukahara K, Endo M, et al. Differences in negative T waves between Takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. <i>Circ J<\/i> 2012; 76: 462\u2013468.","DOI":"10.1253\/circj.CJ-11-1036"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). <i>Circulation<\/i> 2009; 120: 278\u2013285.","DOI":"10.1161\/CIRCULATIONAHA.109.853143"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Marjamaa A, Hiippala A, Arrhenius B, Lahtinen AM, Kontula K, Toivonen L, et al. Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia. <i>J Cardiovasc Electrophysiol<\/i> 2012; 23: 194\u2013199.","DOI":"10.1111\/j.1540-8167.2011.02188.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux-Buisson N, et al. The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands. <i>Europace<\/i> 2012; 14: 1344\u20131351.","DOI":"10.1093\/europace\/eus031"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hofman N, Wilde AA, Kaab S, van Langen IM, Tanck MW, Mannens MM, et al. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: Do we need a scoring system? <i>Eur Heart J<\/i> 2007; 28: 575\u2013580.","DOI":"10.1093\/eurheartj\/ehl355"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kauferstein S, Kiehne N, Erkapic D, Schmidt J, Hamm CW, Bratzke H, et al. A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. <i>Int J Cardiol<\/i> 2011; 146: 249\u2013250.","DOI":"10.1016\/j.ijcard.2010.10.062"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, et al. Exome analysis of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. <i>PLoS One<\/i> 2015; 10: e0130329.","DOI":"10.1371\/journal.pone.0130329"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Taniguchi Y, Miyazaki A, Sakaguchi H, Hayama Y, Ebishima N, Negishi J, et al. Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene. <i>Heart Vessels<\/i> 2017; 32: 229\u2013233.","DOI":"10.1007\/s00380-016-0869-z"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/9\/82_CJ-17-1032\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T04:34:38Z","timestamp":1535171678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/9\/82_CJ-17-1032\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-1032","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}